Updated on 2 October 2012
Mr S Abhaya Kumar, managing director, Shasun, mentioned that countries such as Japan are looking for generic supplies and APIs from India. "The requirement for NCE molecules are also high from India. However, we need to upgrade our quality and work for regulatory compliance which, I feel, is the biggest challenge here," he said.
The panel also unanimously favored the establishment of a centralized pool to assess regulatory compliance by the small and medium enterprises.
Get direct access to more such reports. Subscribe to BioSpectrum Bureau 
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Send this article by email
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
